Daniel Cohen
Pharnext co-founder, SAB Chairman

Pharnext CEO until 2020. Professor of Medical Genetics, founder of modern genetics. Former CSO of Genset and VP Genetics Worldwide of Serono. Co-founder of Millennium Pharma, Genethon and the CEPH research institute.

Doctor Ilya Chumakov
Pharnext co-founder

Pharnext CSO until 2014. Pioneer in genetics, genomics and molecular pharmacology. Former Director at CEPH, Genset and Serono. Author of more than 90 articles, inventor of more than 60 patents.

Professor Eric R. Kandel
Columbia University, New York, USA

Nobel Prize in Medicine in 2000. World expert in Neurosciences and Professor of Biochemistry and Biophysics at Columbia University.

Professor Jean-Marie Lehn
University of Strasbourg, France

Nobel Prize in Chemistry in 1987. Early innovator in the field of supramolecular chemistry. He has published in excess of 900 peer-reviewed articles in chemistry litterature.

Professor David Cornblath
The Johns Hopkins University, Baltimore, USA

Expert in peripheral nerve disorders. Professor of Neurology and Neurosurgery. Editor-in-Chief of the Journal of the Peripheral Nervous System and the Journal of the Peripheral Nerve Society.

Professeur Richard Lewis
Cedars-Sinai Specialty Clinic, Los Angeles, USA

Director of the Electromyography Lab, co-Director of the Neuromuscular Clinic. World expert in inflammatory and inherited neuro-degenerative disorders. Discovered the Lewis-Sumner syndrome.

Professor Klaus Nave
Max Planck institute, Göttingen, Germany

World expert in Neurobiology, leader in Charcot-Marie-Tooth. Director of the Max Planck Institute for Experimental Medicine, Professor of Biology at the University of Heidelberg.

Professor Michael Sereda
Max Planck Institute, Göttingen, Germany

World expert in CMT1A preclinical and clinical work, group leader “Molecular and Translational Neurology”. Specialist in hereditary neuropathies, creator of the PMP22 transgenic rat model.

Professor Fabio Macciardi
University of California, Irvine, USA

Professor in Molecular Psychiatry. Research interests in the non-coding genome of complex psychiatric traits and methods of genetic epidemiology.

Professor Jean-Marc Orgogozo
University of Bordeaux, France

Expert in Neurology and Clinical Pharmacology, particularly in Alzheimer's disease and dementia. Past-head of the Clinical Neuroscience Department, CHU Hospital Pellegrin in Bordeaux.

Doctor Henry Sun
Tasly Pharmaceuticals, China

President and CEO at Tasly Pharmaceuticals, Inc. USA, Vice President at Tasly Group, Co. Ltd. China, Professor at Tianjin University.

Doctor Alan Smith
Genzyme Corporation, Cambridge, USA

Formerly Chief Scientific Officer at Genzyme for more than 15 years. Fellow of the Royal Society of London and of Christ's College Cambridge.

Professor David Klatzmann
Hospital Pitié-Salpêtrière, Paris, France

Worldwide-renowned immunologist and expert in biotherapies.

Doctor Magid Abou Gharbia
Temple University, Philadelphia, USA

Associate Dean for Research, Professor of Medicinal Chemistry and Director of he Moulder Center for Drug Discovery Research at the School of Pharmacy, Temple University, Philadelphia.